Imperial Valley News Center
Small tilt in magnets makes them viable memory chips
- Details
- Written by Sarah Yang
Berkeley, California - UC Berkeley researchers have discovered a new way to switch the polarization of nanomagnets, paving the way for high-density storage to move from hard disks onto integrated circuits.
Heating and cooling with light leads to ultrafast DNA diagnostics
- Details
- Written by Sarah Yang
Berkeley, California - New technology developed by UC Berkeley bioengineers promises to make a workhorse lab tool cheaper, more portable and many times faster by accelerating the heating and cooling of genetic samples with the switch of a light.
An ally for the understudied Y chromosome
- Details
- Written by Julia Sklar
Cambridge, Massachusetts - Alexander Godfrey, a PhD student in biology at MIT, is acutely fascinated by the Y chromosome, which confers maleness. This chromosome is often considered a genetic castaway - because its complexity makes it very difficult to study - but Godfrey is undeterred. Four years into his degree, he continues to push forward, attempting to get to know a chromosome that 50 percent of the population has, but few understand.
Making the new silicon
- Details
- Written by Rob Matheson
Cambridge, Massachusetts - An exotic material called gallium nitride (GaN) is poised to become the next semiconductor for power electronics, enabling much higher efficiency than silicon.
Researchers mount successful attacks against popular anonymity network
- Details
- Written by Larry Hardesty
Cambridge, Massachusetts - With 2.5 million daily users, the Tor network is the world’s most popular system for protecting Internet users’ anonymity. For more than a decade, people living under repressive regimes have used Tor to conceal their Web-browsing habits from electronic surveillance, and websites hosting content that’s been deemed subversive have used it to hide the locations of their servers.
Firms “underinvest” in long-term cancer research
- Details
- Written by Peter Dizikes
Cambridge, Massachusetts - Pharmaceutical firms “underinvest” in long-term research to develop new cancer-fighting drugs due to the greater time and cost required to conduct such research, according to a newly published study co-authored by MIT economists.
Page 3036 of 3785